NCT00399126View on ClinicalTrials.gov

Phase I Trial of Paclitaxel With Perifosine

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

January 31, 2009

Study Completion Date

October 31, 2011

Conditions

Neoplasms

Interventions

DRUG

Perifosine

Perifosine oral dose

DRUG

Paclitaxel

Paclitaxel IV

Trial Locations (1)

37604

AOI Pharmaceuticals Investigative Site, Johnson City

Sponsors

Lead Sponsor

AEterna Zentaris

All Listed Sponsors

lead

AEterna Zentaris

INDUSTRY